Opioid Induced Swallowing Disorders

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Opioid Induced Swallowing Disorders trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (3 shown)

CompletedPhase 3

NCT06522633

Esophageal Dysfunction Associated With Opioids: Clinical Response and Manometric Findings After Opioid Discontinuation

Background: Opioid-induced esophageal dysfunction is characterized by altered motility of the esophageal body or impaired function of the esophageal sphincters…

Spain20 participantsStarted 2020-11-01

Treatment: The intervention involves the discontinuation of the opioid.

CompletedPhase 4

NCT01495377

Opioid Induced Swallowing Difficulties and Risk for Pulmonary Aspiration

The purpose of this study is to determine weather remifentanil induced swallowing difficulties increase risk for pulmonary aspiration.

Sweden25 participantsStarted 2012-01

Treatment: Remifentanil, Placebo

CompletedPhase 4

NCT01191645

Opioid Effects on Swallowing and Esophageal Sphincter Pressure

The purpose of this study is to determine whether a dopamine receptor antagonist metoclopramide can counteract opioid induced effects on esophageal motility and…

Sweden14 participantsStarted 2010-10

Treatment: naloxone, remifentanil